Group One Trading
CPRX

Group One Trading’s Catalyst Pharmaceutical CPRX Stock Holding History

Group One Trading’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84.2K Sell
3,400
-9,700
-74% -$231K ﹤0.01% 4879
2025
Q4 		$306K Sell
13,100
-1,900
-13% -$42.3K ﹤0.01% 4000
2025
Q3 		$296K Buy
15,000
+1,100
+8% +$22.6K ﹤0.01% 4242
2025
Q2 		$302K Sell
13,900
-36,800
-73% -$869K ﹤0.01% 3930
2025
Q1 		$1.23M Buy
50,700
+45,800
+935% +$1.03M ﹤0.01% 2267
2024
Q4 		$102K Sell
4,900
-5,100
-51% -$110K ﹤0.01% 4498
2024
Q3 		$199K Buy
10,000
+8,600
+614% +$159K ﹤0.01% 3617
2024
Q2 		$21.7K Sell
1,400
-50,100
-97% -$780K ﹤0.01% 5163
2024
Q1 		$821K Sell
51,500
-124,900
-71% -$1.88M ﹤0.01% 2264
2023
Q4 		$2.97M Buy
176,400
+147,000
+500% +$2.01M 0.01% 1537
2023
Q3 		$344K Sell
29,400
-41,800
-59% -$559K ﹤0.01% 3295
2023
Q2 		$957K Sell
71,200
-520,000
-88% -$7.48M ﹤0.01% 2402
2023
Q1 		$9.8M Buy
591,200
+557,000
+1,629% +$9.19M 0.04% 471
2022
Q4 		$636K Sell
34,200
-10,200
-23% -$157K ﹤0.01% 2812
2022
Q3 		$570K Buy
44,400
+4,100
+10% +$48.6K ﹤0.01% 3111
2022
Q2 		$283K Buy
40,300
+8,800
+28% +$64.5K ﹤0.01% 3958
2022
Q1 		$261K Buy
31,500
+18,700
+146% +$132K ﹤0.01% 4518
2021
Q4 		$87K Sell
12,800
-49,500
-79% -$326K ﹤0.01% 5851
2021
Q3 		$330K Buy
62,300
+46,500
+294% +$254K ﹤0.01% 4644
2021
Q2 		$91K Sell
15,800
-59,500
-79% -$307K ﹤0.01% 6061
2021
Q1 		$347K Buy
75,300
+66,300
+737% +$263K ﹤0.01% 4443
2020
Q4 		$30K Sell
9,000
-77,600
-90% -$261K ﹤0.01% 5291
2020
Q3 		$257K Buy
86,600
+17,700
+26% +$69.2K ﹤0.01% 3450
2020
Q2 		$318K Buy
68,900
+37,900
+122% +$170K ﹤0.01% 2987
2020
Q1 		$119K Buy
+31,000
New +$127K ﹤0.01% 3157
2019
Q3 		– Sell
-27,200
Closed -$104K – 5196
2019
Q2 		$104K Buy
27,200
+7,700
+39% +$33.3K ﹤0.01% 3319
2019
Q1 		$99K Buy
19,500
+13,900
+248% +$40.9K ﹤0.01% 3183
2018
Q4 		$11K Buy
5,600
+3,600
+180% +$10.3K ﹤0.01% 4222
2018
Q3 		$8K Hold
2,000
– – ﹤0.01% 4711
2018
Q2 		$6K Buy
+2,000
New +$6.07K ﹤0.01% 4763
2017
Q3 		– Sell
-100,000
Closed -$276K – 4870
2017
Q2 		$276K Buy
100,000
+15,000
+18% +$31.3K ﹤0.01% 2414
2017
Q1 		$166K Buy
+85,000
New +$108K ﹤0.01% 2656
2015
Q3 		– Sell
-87,300
Closed -$361K – 4898
2015
Q2 		$361K Buy
87,300
+60,100
+221% +$240K 0.01% 2065
2015
Q1 		$118K Sell
27,200
-19,100
-41% -$68.8K ﹤0.01% 2788
2014
Q4 		$138K Sell
46,300
-67,600
-59% -$186K ﹤0.01% 2596
2014
Q3 		$378K Buy
+113,900
New +$298K 0.01% 1822
2014
Q1 		– Sell
-4,300
Closed -$8K – 5225
2013
Q4 		$8K Buy
+4,300
New +$8.69K ﹤0.01% 4678

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Group One Trading's CPRX Position: Q4 2024 in Review

Group One Trading sold out of Catalyst Pharmaceutical (CPRX) in Q4 2024, closing a stake of 8,108 shares — an estimated $174K sold.

Group One Trading first reported a position in CPRX in Q4 2013 and held it in 21 quarters. The position peaked at $992K in Q3 2019. 336 funds tracked by Wall St. Rank hold CPRX as of Q4 2024.

  • Group One Trading reported no remaining Catalyst Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 8,108 Catalyst Pharmaceutical shares in Q4 2024, an estimated $174K.
  • Group One Trading first reported a position in Catalyst Pharmaceutical in Q4 2013 and held it in 21 quarters.
  • Group One Trading's Catalyst Pharmaceutical position peaked at $992K in Q3 2019.
  • 336 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.